Capital Investment Counsel Inc decreased its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA – Free Report) by 11.6% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 12,915 shares of the pharmacy operator’s stock after selling 1,700 shares during the quarter. Capital Investment Counsel Inc’s holdings in Walgreens Boots Alliance were worth $120,000 as of its most recent SEC filing.
Several other large investors also recently bought and sold shares of WBA. Sequoia Financial Advisors LLC increased its holdings in Walgreens Boots Alliance by 4.4% during the 3rd quarter. Sequoia Financial Advisors LLC now owns 25,215 shares of the pharmacy operator’s stock worth $226,000 after purchasing an additional 1,063 shares during the period. Eastern Bank purchased a new stake in Walgreens Boots Alliance during the 3rd quarter worth about $33,000. International Assets Investment Management LLC increased its holdings in Walgreens Boots Alliance by 701.3% during the 3rd quarter. International Assets Investment Management LLC now owns 282,619 shares of the pharmacy operator’s stock worth $2,532,000 after purchasing an additional 247,350 shares during the period. IFM Investors Pty Ltd increased its holdings in Walgreens Boots Alliance by 2.5% during the 3rd quarter. IFM Investors Pty Ltd now owns 151,527 shares of the pharmacy operator’s stock worth $1,358,000 after purchasing an additional 3,740 shares during the period. Finally, Ballentine Partners LLC purchased a new stake in Walgreens Boots Alliance during the 3rd quarter worth about $164,000. Hedge funds and other institutional investors own 58.59% of the company’s stock.
Analyst Ratings Changes
Several brokerages have weighed in on WBA. Evercore ISI upped their price target on Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an “in-line” rating in a report on Monday, January 13th. Truist Financial dropped their price objective on Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating on the stock in a report on Friday, January 31st. Royal Bank of Canada increased their price objective on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a “sector perform” rating in a report on Wednesday, January 15th. Finally, Bank of America increased their price objective on Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an “underperform” rating in a report on Monday, January 13th. Three equities research analysts have rated the stock with a sell rating, nine have given a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $12.63.
Walgreens Boots Alliance Stock Down 3.3 %
WBA opened at $10.16 on Friday. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.64 and a quick ratio of 0.30. The business has a 50 day simple moving average of $10.37 and a 200-day simple moving average of $9.71. The stock has a market capitalization of $8.78 billion, a P/E ratio of -0.99, a P/E/G ratio of 1.35 and a beta of 0.65. Walgreens Boots Alliance, Inc. has a 12 month low of $8.08 and a 12 month high of $22.05.
Walgreens Boots Alliance (NASDAQ:WBA – Get Free Report) last posted its quarterly earnings results on Friday, January 10th. The pharmacy operator reported $0.51 EPS for the quarter, beating the consensus estimate of $0.38 by $0.13. The business had revenue of $39.50 billion during the quarter, compared to analysts’ expectations of $37.40 billion. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The company’s quarterly revenue was up 7.6% compared to the same quarter last year. During the same period last year, the firm earned $0.66 EPS. On average, equities analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current fiscal year.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.
See Also
- Five stocks we like better than Walgreens Boots Alliance
- 3 Monster Growth Stocks to Buy Now
- 3 Stocks Poised to Thrive as NVIDIA Dominates the AI Boom
- Where to Find Earnings Call Transcripts
- MercadoLibre: High-Growth EM Stock With 100% Upside Potential
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- As the Magnificent 7 Stalls, These 3 Stocks Are Gaining Momentum
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA – Free Report).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.